MMA Embolization for Refractory Chronic Migraine

Recruiting N/A Interventional Study
Migraine Disorders
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Device Feasibility
Participants needed
70 (estimated)
Sponsor
Cerenovus, Part of DePuy Synthes Products, Inc. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Participant Inclusion Criteria, Candidates for this study must meet ALL the following inclusion criteria: 1. Patient is between 18 and 65 years of age (inclusive) at the time of consent 2. Age of onset of Chronic Migraine \<= 64 years 3. Age of onset of migraine diagnosis \< 50 years 4. Patient has…
Contacts

Study Contact

RA-MIGRAINECNV202302@ITS.JNJ.com

CONTACT